Chun-Jen Liu - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Chun-Jen Liu

Showing results (251-260 of 400) with videos related to

Pageof 40

Sort By:

Proceedings of the National Academy of Sciences of the United States of America|February 16, 2011

Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapyChing-Sheng Hsu, Shih-Jer Hsu, Hung-Chia Chen, et al.

Molecular Therapy. Nucleic Acids|April 12, 2020

Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base EditingYu-Chan Yang, Yu-Hsiang Chen, Jia-Horng Kao, et al.

JHEP Reports : Innovation in Hepatology|December 13, 2023

HBcrAg-based risk score performs better than the HBV DNA-based scores for HCC prediction in grey zone patients who are HBeAg-negativeTai-Chung Tseng, Tetsuya Hosaka, Chun-Jen Liu, et al.

Gut Pathogens|June 17, 2023

Correction: Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver diseaseMeng-Ju Lin, Tung-Hung Su, Chieh-Chang Chen, et al.

Journal of Hepatology|February 2, 2020

HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosisTai-Chung Tseng, Chun-Jen Liu, Crystal T Chang, et al.

Liver International : Official Journal of the International Association for the Study of the Liver|December 10, 2021

Hepatocellular carcinoma after treatment cessation in non-cirrhotic HBeAg-negative chronic hepatitis B: A multicentre cohort studyMargarita Papatheodoridi, Tung-Hung Su, Emilia Hadziyannis, et al.

Journal of Gastroenterology and Hepatology|July 5, 2022

The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in TaiwanChih-Lin Lin, Chi-Ming Tai, Jee-Fu Huang, et al.

Frontiers in Endocrinology|April 26, 2021

Mining Gut Microbiota From Bariatric Surgery for MAFLDWei-Kai Wu, Yi-Hsun Chen, Po-Chu Lee, et al.

Hepatology (Baltimore, Md.)|June 27, 2002

Androgen receptor exon 1 CAG repeat length and risk of hepatocellular carcinoma in womenMing-Whei Yu, Yu-Ching Yang, Shi-Yi Yang, et al.

Cancer|September 6, 2024

Outcomes of radiofrequency ablation for hepatocellular carcinoma with concurrent steatotic liver diseaseFeng-Pai Tsai, Tung-Hung Su, Shang-Chin Huang, et al.

Pageof 40

Search research articles

Showing results (251-260 of 400) with videos related to

Sort By:

Pageof 40

Proceedings of the National Academy of Sciences of the United States of America|February 16, 2011

Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapyChing-Sheng Hsu, Shih-Jer Hsu, Hung-Chia Chen, et al.

Molecular Therapy. Nucleic Acids|April 12, 2020

Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base EditingYu-Chan Yang, Yu-Hsiang Chen, Jia-Horng Kao, et al.

JHEP Reports : Innovation in Hepatology|December 13, 2023

HBcrAg-based risk score performs better than the HBV DNA-based scores for HCC prediction in grey zone patients who are HBeAg-negativeTai-Chung Tseng, Tetsuya Hosaka, Chun-Jen Liu, et al.

Gut Pathogens|June 17, 2023

Journal of Hepatology|February 2, 2020

HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosisTai-Chung Tseng, Chun-Jen Liu, Crystal T Chang, et al.

Liver International : Official Journal of the International Association for the Study of the Liver|December 10, 2021

Hepatocellular carcinoma after treatment cessation in non-cirrhotic HBeAg-negative chronic hepatitis B: A multicentre cohort studyMargarita Papatheodoridi, Tung-Hung Su, Emilia Hadziyannis, et al.

Journal of Gastroenterology and Hepatology|July 5, 2022

The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in TaiwanChih-Lin Lin, Chi-Ming Tai, Jee-Fu Huang, et al.

Frontiers in Endocrinology|April 26, 2021

Mining Gut Microbiota From Bariatric Surgery for MAFLDWei-Kai Wu, Yi-Hsun Chen, Po-Chu Lee, et al.

Hepatology (Baltimore, Md.)|June 27, 2002

Androgen receptor exon 1 CAG repeat length and risk of hepatocellular carcinoma in womenMing-Whei Yu, Yu-Ching Yang, Shi-Yi Yang, et al.

Cancer|September 6, 2024

Outcomes of radiofrequency ablation for hepatocellular carcinoma with concurrent steatotic liver diseaseFeng-Pai Tsai, Tung-Hung Su, Shang-Chin Huang, et al.

Pageof 40